Closed
Strategic Operating Grant Program
Research funding for arthritis priorities
Last Update: May 26, 2026
Funding available
$ 150,000
Timeline
- Closing date : April 9, 2025
Location
Canada
Overview
This program funds research proposals aligned with Arthritis Society Canada’s priorities, with a focus on pain, osteoarthritis, inflammatory arthritis, childhood arthritis, and workplace-related research. The maximum funding is $150,000 per year for up to three years, for a total of $450,000, and the award is non-renewable.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Maximum amount : 150,000 $
Timeline
- Closing date : April 9, 2025
Eligible candidates
Eligible Industries
- Health care and social assistance
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- All the groups
Revenue structures
- All structures
Scope
- All dimensions
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Research proposals aligned with Arthritis Society Canada’s priorities.
- Innovative research in pain.
- Innovative research in osteoarthritis.
- Innovative research in inflammatory arthritis.
- Innovative research in childhood arthritis and workplace-related arthritis.
Eligibility
Who is eligible?
- Eligible Principal Investigators.
- Canadian host institutions.
Eligible geographic areas
- Canada
Processing and Agreement
- Letters of intent are reviewed first.
- Applicants are notified of LOI review results in July.
Additional information
- Applications are tied to Arthritis Society Canada’s research priorities.
- The program is part of the 2020-2027 Strategic Plan: Accelerating Impact - Research Strategy.
- Applicants are notified of LOI review results in July.
Frequently Asked Questions about the Strategic Operating Grant Program Program
Here are answers to the most common questions about the Strategic Operating Grant Program. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Strategic Operating Grant Program?
This program funds research proposals aligned with Arthritis Society Canada’s priorities, with a focus on pain, osteoarthritis, inflammatory arthritis, childhood arthritis, and workplace-related research. The maximum funding is $150,000 per year for up to three years, for a total of $450,000, and the award is non-renewable.
How much funding can be received?
Strategic Operating Grant Program Funds up to $150,000 of admissible expenses.
Who is eligible for the Strategic Operating Grant Program program?
To be eligible for the Strategic Operating Grant Program program, you must:
Eligible Principal Investigator required.
Canadian host institution required.
Research must match program priorities.
What expenses are eligible under Strategic Operating Grant Program?
Research proposals aligned with Arthritis Society Canada’s priorities.
Innovative research in pain.
Innovative research in osteoarthritis.
Innovative research in inflammatory arthritis.
Innovative research in childhood arthritis and workplace-related arthritis.
Who can I contact for more information about the Strategic Operating Grant Program?
You can contact Arthritis Society Canada (ASC).
Where is the Strategic Operating Grant Program available?
The Strategic Operating Grant Program program is available across Canada.
Is the Strategic Operating Grant Program a grant, loan, or tax credit?
Strategic Operating Grant Program is a Grant and Funding